Zeiss laser tech to treat astigmatismDecember 13, 2018
Carl Zeiss Meditec’s expanding myopia treatment for patients with astigmatism received premarket approval from the USFDA.
ReLEx Smile utilises a high-precision femtosecond laser to create a lenticule inside the cornea and access incision in a single treatment step. Incisions are made through microscopic-photodisruptions of tissue, created by ultrashort pulses. VisuMax laser is the first femtosecond laser to receive FDA PMA approval for the treatment of a refractive indication in addition to 510k clearances for LASIK flap, keratoplasty, and ICR.
The technology behind Smile was recently featured in the scientific background on the Nobel Prize in Physics 2018. Dr. Gérard Mourou and Dr. Donna Strickland were awarded the Nobel Prize for his method to generate high-intensity ultrashort optical pulses. Their invention of so-called chirped pulse amplification is essential to generate the ultrashort laser pulses of the Zeiss VisuMax femtosecond laser system, according to the company.
Carl Zeiss Meditec AG is the Medical Technology Business Group of Zeiss.